ORBIMED ADVISORS LLC 13D and 13G filings for Gemini Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-22 3:47 pm Purchase |
2021-02-05 | 13D | Gemini Therapeutics, Inc. GMTX |
ORBIMED ADVISORS LLC | 582,622 12.900% |
582,622 (New Position) |
Filing |